Chemosensitivity prediction in tumor cells ex vivo - Difficulties and limitations of the method;Predikce citlivosti nádorových buněk k chemoterapeutikům ex vivo - Úskalí a limitace vlastní metody

Klinicka Onkologie

Volumn 21, Issue 3, 2008, Pages 93-97

  Michalová, Eva ^a,b   Poprach, A ^a   Nemeckova I ^a   Nenutil, R ^a   Valik D ^a   Zaloudik J ^a   Vyzula, R ^a   Vojtesek B ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b Oddělení Laboratorní Medicíny ^*  (Czech Republic)

Author keywords

Chemoresistance; Cytostatic agents; MTT test; Neoplasms

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE;

CANCER CHEMOTHERAPY; CANCER PATIENT; CHEMOSENSITIVITY; EX VIVO STUDY; HUMAN; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; REVIEW; TECHNIQUE; TUMOR CELL;

DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; TUMOR CELLS, CULTURED;

EID: 46449134100     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Lichý, J.H., Dalbergue, F., Washington, C. et al. Genetic heterogeneity in ductal carcinoma of the breast. Lab Invest, 2000, 80: 291-301.
2. Black, M.M., Speer, F.D. Further observation on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue. J Natl Cancer Inst, 1954, 14: 1147-1158.
3. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65: 55-63.
4. Carmichael, J., De Graff, W., Gazdar, A. et al. Evaluation of a tetrazolium-based semi-automatic colorimetric assay: Assessment of chemosensitivity testing. Cancer Research, 1987, 47: 936-942.
5. Slater, T.F., Sawyer, B., Strnuli, U. Studies on succinate-tetrazolium reductase systems III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta, 1963, 77: 383-393.
6. Denizot, F., Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods, 1986, 89: 271-277.
7. Berridge, M.V., An, S.T., McCoy, K.D., Wang, R. The Biochemical and Cellular Basis of Cell Proliferation Assays That Use Tetrazolium Salts. Biochemica, 1996, 4: 15-19.
8. Suto, A., Kubota, T., Shimoyama, Y. et al. MTT assay with reference to the clinical effect of chemotherapy, J Surg Oncol, 1989, 42: 28-32.
9. Furukawa, T., Kubota, T., Suto, A. et al. Clinical usefulness of chemosensitivity testing using the MTT assay, J Surg Oncol, 1991, 48: 188-193.
10. Saikawa, Y., Kubota, T., Furukawa, T. et al. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer, Jpn J Cancer Res, 1994, 85: 762-765.
11. Yamaue, H., Tanimura, H., Nakamori, M. et al. Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum, 1996, 39: 416-422.
12. Freshney, R. Culture of Animal Cells: A Manual of Basic Technique, 1987, p. 117, Alan R. Liss, Inc., New York.
13. Xu, J.M., Song, S.T., Tang, Z.M. et al. Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res Treat, 1999, 53: 77-85.
14. Bøyum, A. Separation of leucocytes from blood and bone marrow. Introduction. Scand J Clin Invest Suppl, 1968, 97: 7.
15. Yamaue, H., Tanimura, H., Tsunoda, T. et al. Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay. Eur J Cancer, 1991, 27: 1258-1263.
16. Yamaue, H., Tanimura, H., Noguchi, K. et al. Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using MTT assay. Br J Cancer, 1992, 66: 794-799.
17. Krásná, L., Matoušková, E., Janoušek, M., et al. Využití buněk získaných z maligních výpotků k vedení léčby pacientů s pokročilým nádorem. Klinická ontologie, 2000, 13 (zvl. .č 2): 43-48.
18. Shimoyama, Y., Kubota, T., Watanabe, M. et al. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay. J Surg Oncol, 1989, 41: 12-18.
19. Yano, T., Teruya, K., Shirahata, S. et al. Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology, 1994, 16: 167-178.
20. Takenouchi, T., Munekata, E. Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci, 1995, 56: PL479-484.
21. Regner, B., Dušek, L., Hajduch, M. Software chemorezist (verze 1.0) - komplexní nástroj pro analýzu dat a management testů chemorezistence nádorů. Klinická onkologie, 2000, 13 (zvl. č. 2): 30-32.
22. Di Nicolantonio, F., Mercer, S.J., Knight, L.A. et al. Cancer cell adaptation to chemotherapy. BMC Cancer, 2005, 5: 78.